Chiron Capital Management, LLC Alaunos Therapeutics, Inc. Transaction History

Chiron Capital Management, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$0.04 - $0.13 $391 - $1,272	-9,790 Reduced 12.71%	67,233 $4,000
Q3 2023 Nov 14, 2023	SELL	$0.12 - $0.5 $312 - $1,303	-2,607 Reduced 3.27%	77,023 $10,000
Q2 2023 Jul 27, 2023	SELL	$0.43 - $0.65 $946 - $1,430	-2,200 Reduced 2.69%	79,630 $40,000
Q1 2023 Apr 21, 2023	SELL	$0.46 - $0.81 $11,067 - $19,488	-24,060 Reduced 22.72%	81,830 $51,000
Q4 2022 Jan 23, 2023	SELL	$0.5 - $261.0 $5,485 - $2.86 Million	-10,970 Reduced 9.39%	105,890 $0
Q3 2022 Oct 13, 2022	SELL	$1.04 - $322.5 $8,008 - $2.48 Million	-7,700 Reduced 6.18%	116,860 $201,000
Q2 2022 Jul 25, 2022	SELL	$0.41 - $1.24 $8,364 - $25,296	-20,400 Reduced 14.07%	124,560 $154,000
Q1 2022 Apr 18, 2022	BUY	$0.62 - $1.17 $15,896 - $29,998	25,640 Added 21.49%	144,960 $95,000
Q4 2021 Jan 18, 2022	SELL	$1.09 - $1.89 $85,763 - $148,708	-78,682 Reduced 39.74%	119,320 $130,000
Q3 2021 Oct 21, 2021	SELL	$1.44 - $2.73 $4,262 - $8,080	-2,960 Reduced 1.47%	198,002 $360,000
Q2 2021 Jul 20, 2021	BUY	$2.63 - $3.67 $3,050 - $4,257	1,160 Added 0.58%	200,962 $531,000
Q1 2021 May 18, 2021	SELL	$2.82 - $5.6 $3,384 - $6,720	-1,200 Reduced 0.6%	199,802 $719,000
Q4 2020 Mar 05, 2021	SELL	$2.09 - $3.09 $978 - $1,446	-468 Reduced 0.23%	201,002 $507,000
Q3 2020 Nov 19, 2020	BUY	$2.39 - $3.43 $481,513 - $691,042	201,470 New	201,470 $508,000

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $458M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Chiron Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Chiron Capital Management, LLC with notifications on news.